Project Grant R01AI186222
- This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research investigating the mechanisms underlying beneficial effects of influenza A virus co-infection on viral replication and propagation. Awarded to Emory University in the amount of $246,562, the project runs from June 27, 2025, through January 31, 2028. The research focuses on understanding positive...
- This National Science Foundation Project Grant of $365,556 supports collaborative research between mathematicians, biologists, and engineers at the University of Wisconsin-Madison to develop new mathematical tools and biological experiments essential to understanding virus spread and extinction. Funded through the NSF's Biological Sciences program (CFDA 47.074), the research will establish an integrated experimental-mathematical framework to study how spatial structure affects viral evolution...
- This Project Grant award from the National Science Foundation (NSF) under the Biological Sciences (CFDA 47.074) Federal Grant Program provides $987,566 to the University of California, Los Angeles (UCLA) to conduct research on viral self-assembly, from test tube to cell cytoplasm. The award period runs from December 15, 2024 to November 30, 2028. The key objectives of this project are to elucidate the differences between in vitro and in cellulo viral processes by progressively adding molecules...
- This $195,101 Project Grant, awarded by the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074), will use mathematical modeling to project the healthcare burden associated with COVID-19, influenza, and respiratory syncytial virus (RSV) in the United States during the 2023-2024 respiratory virus season. The research will integrate estimates of population immunity from prior infections, vaccinations, and monoclonal antibody therapy to produce four rounds of projections...
- The Flavivirus and Alphavirus REVAMPP (FLARE) Center, funded by a $46,715,173 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), is developing and optimizing protein nanoparticle, virion-based, and mRNA vaccine platforms, as well as monoclonal antibody-based treatments to rapidly respond to emerging flaviviruses and alphaviruses with pandemic potential. The Center integrates the work of multiple...
- This Project Grant award of $392,500.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports a research program at Arizona State University (ASU) focused on improving the understanding of cross-species viral transmission from wild mammals to humans. The key objectives of the five-year project are to: 1) develop automated tools to curate and maintain up-to-date taxonomic data on mammal and virus species, 2) test...
- This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...
- Federal Project Grant Award Summary Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received a $530,385 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 6, 2025, with completion targeted for May 31, 2030. The award supports biomedical research investigating host regulation of flavivirus infection, specifically examining how host cell factors...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,074,701 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Emory University. The project, titled "Drivers of Influenza A Virus Transmission in Humans," aims to address gaps in understanding the biological and physical processes underlying the transmission of influenza A virus in humans. The key objectives are to: 1) Define the dynamics of viral load, immunological...
- Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $429,000 Project Grant to the University of Texas at Dallas under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2027. This research project develops innovative measurement methodologies to characterize the spatial distribution of chemicals and pathogens within bioaerosols, with particular focus on understanding how virus viability is affected by...
IN SILICO MODELING OF SUBCELLULAR INFECTION BY DIVERSE FAMILIES OF RNA VIRUS - PROJECT SUMMARY/ABSTRACT RNA VIRUSES ARE THE LEADING SOURCE OF EXISTING AND EMERGING PATHOGENS. MANY SPECIES OVERTAKE HOST CELLS WITH JUST A DOZEN OR SO VIRAL COMPONENTS, MAKING SUBCELLULAR INFECTIONS TRACTABLE FOR MATHEMATICAL MODELING AND ANALYSIS. SUCH MODELS HAVE THE POTENTIAL TO IDENTIFY FRAGILITIES IN A VIRAL LIFE CYCLE, EXAMINE DIFFERENCES IN SUSCEPTIBILITY AMONG HUMANS, AND SERVE AS TEMPLATES FOR RECONFIGURATION IN RESPONSE TO NOVEL OUTBREAKS. HOWEVER, IT HAS NOT BEEN CLEAR HOW TO BUILD SUCH MODELS IN A SCALABLE WAY, AND THUS FEWER THAN TEN HAVE BEEN DEVELOPED AMONG THE SEVERAL HUNDRED RNA VIRUSES THAT INFECT HUMANS. A NEW MODELING STRATEGY WAS RECENTLY PROPOSED, WHICH STARTS WITH A COMMON MASS-ACTION TOPOLOGY THAT IS THEN CUSTOMIZED TO DIFFERENT VIRUS FAMILIES BY PARAMETER INFERENCE. THE GENERIC APPROACH LUMPS TOGETHER BIOCHEMICAL PROCESSES THAT ARE SPECIFIC TO DIFFERENT VIRUS FAMILIES, AND IT IS UNCLEAR WHETHER THESE DISTINCTIONS ARE NEEDED TO CREATE MODELS THAT ARE BROADLY PREDICTIVE. THE OBJECTIVE OF THIS APPLICATION IS TO EVALUATE THE RELATIVE MERITS OF GENERIC AND FAMILYSPECIFIC APPROACHES FOR MODELING SUBCELLULAR INFECTION BY RNA VIRUSES. WE FOCUS ON COXSACKIEVIRUS B3 AND DENGUE VIRUS AS TWO SPECIES OF RNA VIRUS FROM DIFFERENT FAMILIES (PICORNAVIRIDAE AND FLAVIVIRIDAE) FOR WHICH GENERIC AND FAMILY-SPECIFIC MODELS ARE AVAILABLE OR IMMEDIATELY FEASIBLE. THE OVERARCHING HYPOTHESIS IS THAT RNA VIRUSES ARE SIMILARLY ORGANIZED AROUND MODULES FOR ENTRY, REPLICATION, AND OTHER CORE PROCESSES, BUT THE MODULES FUNDAMENTALLY DIFFER BY VIRUS FAMILY. THE SPECIFIC AIMS ARE TO: 1) COMPARE LUMPED VIRAL ENTRY TO FAMILY-SPECIFIC MODULES; 2) REFACTOR THE VIRAL REPLICATION MODULE; AND 3) ADD ANTIVIRAL CONDUITS BETWEEN MODULES. OUR APPROACH LEVERAGES DEEP TRANSCRIPTOME PROFILES FROM SEVERAL THOUSAND SINGLE CELLS AND SEVERAL HUNDRED RELEVANT HUMAN ORGANS; IT ALSO INVOKES A NEW ABSTRACTION (THE PHASE-FIELD CRYSTAL MODEL) FOR A KEY INTERMEDIATE OF RNA VIRUSES. COMPUTATIONAL AND EXPERIMENTAL TESTS WILL BE PERFORMED USING TEMPERATURE AS A SYSTEM-WIDE PERTURBATION OF BIOCHEMICAL RATE PARAMETERS AT SURFACE (33C), BODY (37C), AND FEBRILE (40C) TEMPERATURES. THIS MULTI-PRONGED ASSESSMENT ACROSS DIFFERENT MODULES WILL CLARIFY A BEST-AVAILABLE PATH TOWARD BUILDING FOUNDATIONAL MODELS FOR ALL MAJOR FAMILIES OF RNA VIRUSES THAT INFECT HUMANS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $542.7k | 4/14/25 | ||
| Not listed | $54.8k | 9/4/24 | ||
| Not listed | $54.8k | 9/4/24 | ||
| Not listed | $508.8k | 5/28/24 | ||
| Not listed | $508.8k | 5/28/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
GR103856SUB00001126S | University Of California Irvine | Project Grant R01AI186222 | $52.8k | 7/5/24 |